MSB 4.52% 95.0¢ mesoblast limited

Cell Therapy News/Articles, page-7694

  1. 12,319 Posts.
    lightbulb Created with Sketch. 1103
    Hi,
    Still seems odd, The FDA NIH ARDS trial is an approvable 300 person trial
    with 2 read outs completed and a 60% soon.

    How do you add to it and is it under control of the FDA.

    Mesoblast really should be informing scrip holders of such developments before our resident
    sleuths find out. Not the first time either.

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
95.0¢
Change
-0.045(4.52%)
Mkt cap ! $1.084B
Open High Low Value Volume
$1.00 $1.01 94.5¢ $2.669M 2.769M

Buyers (Bids)

No. Vol. Price($)
1 2053 95.0¢
 

Sellers (Offers)

Price($) Vol. No.
95.5¢ 13191 2
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.